Charles Schwab Investment Management Inc Adicet Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 30,000 shares of ACET stock, worth $27,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,040
0.13%
Holding current value
$27,000
Previous $43,000
34.88%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ACET
# of Institutions
71Shares Held
59.1MCall Options Held
4.2KPut Options Held
6.7K-
Orbimed Advisors LLC San Diego, CA11.4MShares$10.3 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$7.4 Million1.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$6.79 Million0.15% of portfolio
-
Goldman Sachs Group Inc New York, NY3.76MShares$3.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.89 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $36M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...